Table 2.
Demographic and clinical features of patients with AD.
| CG (N. 13) | EG (N. 9) | p | |
|---|---|---|---|
| Females/males (N.) | 8/5 | 6/3 | 0.82 |
| Age (mean ± SD, y) | 78.92 + 8.04 | 78.89 + 6.68 | 0.99 |
| Education level (mean ± SD, y) | 8.31 + 5.17 | 7.89 + 5.49 | 0.86 |
| BMI (mean ± SD, kg/m2) | 25.20 + 2.16 | 27.00 + 2.66 | 0.09 |
| Medical History (N; %) | |||
| Smoke | 2; 15.3% | 3; 33.3% | 0.30 |
| Dyslipidemia | 2; 15.3% | 2; 22.2% | 0.68 |
| Diabetes | 1; 7.7% | 2; 22.2% | 0.32 |
| Hypertension | 6; 46.1% | 2; 22.2% | 0.25 |
| Myocardial infarction | 0 | 1; 11.1% | 0.21 |
| TIA/Stroke | 0 | 0 | |
| Drugs (N; %) | |||
| Antihypertensive | 4; 30.7% | 2; 22.2% | 0.89 |
| Lipid-lowering | 2; 15.3% | 2; 22.2% | 0.46 |
| Hypoglycemic | 1; 7.7% | 2; 22.2% | 0.32 |
| Memantine | 7; 53.8% | 3; 33.3% | 0.18 |
| AChE-I | 7; 53.8% | 4; 44.4% | 0.20 |
CG: control group; EG: experimental group; BMI: body mass index; TIA: transient ischemic attack; AChE-I: acetylcholinesterase inhibitors.